Preoxygenation With Optiflow™ in Morbidly Obese Patients is Superior to Face Mask

NCT03009877 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped withdrawn prior to IRB approval

Conditions

Obesity, Morbid

Interventions

DEVICE: Optiflow F&P 850™ System
DEVICE: facemask
DRUG: Rocuronium
DRUG: Propofol
DRUG: Fentanyl
DRUG: Midazolam
DEVICE: C-MAC Premium Video Intubation Platform-KARL STORZ

Sponsor

Montefiore Medical Center

Collaborators

[object Object]
[object Object]